Boston Scientific (BSX) vs Medtronic (MDT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Medtronic (MDT) has outperformed Boston Scientific (BSX) over the past year, losing 12.6% versus a loss of 56.3%. Over five years, BSX leads with a -3.4% price change compared with -32.7% for MDT. Medtronic is the larger company by market cap ($109.38 billion vs $60.26 billion), about 1.8 times the size, while Boston Scientific is growing revenue faster (+19.9% vs +8.4%).
On valuation, Boston Scientific trades at a lower forward P/E (12.3x vs 13.3x for Medtronic). Medtronic pays a dividend yielding 3.33%, while Boston Scientific does not currently pay one. Boston Scientific converts more of its revenue into profit, with a net margin of 14.4% versus 13.2%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BSX | MDT |
|---|---|---|
| Share price | $41.58 | $85.51 |
| Market cap | $60.26B | $109.38B |
| 1-day change | -1.45% | -1.81% |
| YTD return | -56.01% | -10.54% |
| 1-year return | -56.26% | -12.60% |
| 5-year return | -3.35% | -32.73% |
| P/E ratio (TTM) | 16.83 | 21.01 |
| Forward P/E | 12.29 | 13.33 |
| EPS (TTM) | $2.47 | $4.07 |
| Dividend yield | 0.00% | 3.33% |
| Annual dividend | $0.00 | $2.85 |
| Revenue (latest FY) | $20.07B | $36.36B |
| Revenue growth (YoY) | +19.87% | +8.43% |
| Net income (latest FY) | $2.89B | $4.80B |
| Gross margin | 69.01% | 65.02% |
| Operating margin | 18.00% | 17.78% |
| Net margin | 14.41% | 13.20% |
| 52-week high | $105.65 | $106.33 |
| 52-week low | $41.50 | $73.31 |
| Distance from 52-week high | -60.64% | -19.58% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +44.06% | +22.14% |
| Average volume | 19.67M | 10.71M |
| Shares outstanding | 1.45B | 1.28B |
| Employees | 59,000 | 95,000 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MDT has outperformed BSX by 43.7 percentage points over the past year.
- Medtronic offers a meaningfully higher dividend yield (3.33% vs 0.00%).
- Boston Scientific grew revenue faster in its latest fiscal year (+19.87% vs +8.43%).
About Boston Scientific
BSX stock →Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular.
Healthcare · Medical Devices · 59,000 employees
About Medtronic
MDT stock →Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio.
Healthcare · Medical Devices · 95,000 employees
BSX vs MDT FAQ
Which is bigger, Boston Scientific or Medtronic?
Medtronic (MDT) is larger, with a market capitalization of $109.38B compared with $60.26B for Boston Scientific (BSX).
Which stock has performed better over the past year, BSX or MDT?
MDT returned -12.60% over the past 12 months, compared with -56.26% for BSX (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, BSX or MDT?
BSX has the lower trailing P/E at 16.8, versus 21.0 for MDT. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Boston Scientific or Medtronic?
Medtronic pays a dividend yielding 3.33%, while Boston Scientific does not currently pay a regular dividend.
Are Boston Scientific and Medtronic in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.